1. |
Yousef YA, Soliman SE, Astudillo PPP, et al. Intra-arterial chemotherapy for retinoblastoma: a systematic review[J]. JAMA Ophthalmol, 2016, 134(5): 584-591. DOI: 10.1001/jamaophthalmol.2016.0244.
|
2. |
Shields CL, Shields JA. Intra-arterial chemotherapy for retinoblastoma[J/OL]. JAMA Ophthalmol, 2016, 134(10): 1201[2016-10-01]. https://pubmed.ncbi.nlm.nih.gov/27533705/. DOI: 10.1001/jamaophthalmol.2016.2712.
|
3. |
Abramson DH, Marr BP, Francis JH. Intra-arterial chemotherapy for retinoblastoma[J/OL]. JAMA Ophthalmol, 2016, 134(10): 1202[2016-10-01]. https://pubmed.ncbi.nlm.nih.gov/27533893/. DOI: 10.1001/jamaophthalmol.2016.2714.
|
4. |
Chantada G, Schaiquevich P. Intra-arterial chemotherapy for retinoblastoma[J]. JAMA Ophthalmol, 2016, 134(10): 1202-1203. DOI: 10.1001/jamaophthalmol.2016.2724.
|
5. |
Soliman SE, Gallie BL, Shaikh F. Intra-arterial chemotherapy for retinoblastoma—reply[J/OL]. JAMA Ophthalmol, 2016, 134(10): 1203[2016-10-01]. https://pubmed.ncbi.nlm.nih.gov/27532440/. DOI: 10.1001/jamaophthalmol.2016.2759.
|
6. |
Shields CL, Shields JA. Basic understanding of current classification and management of relinoblastoma[J]. Curr Opin Ophthalmol, 2006, 17(3): 228-234. DOI: 10.1097/01.icu.0000193079.55240.18.
|
7. |
Mallipatna A, Gallie BL, Chévez-Barrios P, et al. Retinoblastoma[M]//Amin MB, Edge SB, Greene FL. AJCC cancer staging manual. 8th ed. New York: Springer, 2017: 819-831.
|
8. |
中华医学会眼科学分会眼底病学组, 中华医学会儿科学分会眼科学组, 中华医学会眼科学分会眼整形眼眶病学组. 中国视网膜母细胞瘤诊断和治疗指南(2019年)[J]. 中华眼科杂志, 2019, 55(10): 726-738. DOI: 10.3760/cma.j.issn.0412-4081.2019.10.003.Fundus Diseases Group of Ophthalmology Branch of Chinese Medical Association, Ophthalmology Group of Pediatrics Branch of Chinese Medical Association, Ophthalmology Orbital Disease Group of Ophthalmology Branch of Chinese Medical Association. Guidelines for diagnosis and treatment of retinoblastoma in China (2019)[J]. Chin J Ophthalmol, 2019, 55(10): 726-738. DOI: 10.3760/cma.j.issn.0412-4081.2019.10.003.
|
9. |
魏文斌, 周楠. 重视视网膜母细胞瘤的规范化治疗, 提升视网膜母细胞瘤的治疗水平[J]. 中华眼底病杂志, 2020, 36(6): 413-418. DOI: 10.3760/cma.j.cn511434-20200520-00209.Wei WB, Zhou N. Attach importance to standardized treatment of retinoblastoma to improve its treatment outcome[J]. Chin J Ocul Fundus Dis, 2020, 36(6): 413-418. DOI: 10.3760/cma.j.cn511434-20200520-00209.
|
10. |
Dimaras H, Corson TW, Cobrinik D, et al. Retinoblastoma[J/OL]. Nat Rev Dis Primers, 2015, 27 (1): 15021[2015-08-27]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744255/. DOI: 10.1038/nrdp.2015.21.
|
11. |
Shields CL, Fulco E, Arias JD, et al. Retinoblastoma frontiers with intravenous, intra-arterial, periocular and intravitreal chemotherapy[J]. Eye (Lond), 2013, 27(2): 253-264. DOI: 10.1038/eye.2012.175.
|
12. |
Shields CL, Manjandavida FP, Lally SE, et al. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma[J]. Ophthalmology, 2014, 121(7): 1453-1460. DOI: 10.1016/j.ophtha.2014.01.026.
|
13. |
Shields CL, Mashayekhi A, Au AK, et al. The international classification of retinoblastoma predicts chemoreduction success[J]. Ophthalmology, 2006, 113(12): 2276-2280. DOI: 10.1016/j.ophtha.2006.06.018.
|
14. |
Shields CL, Jorge R, Say EA, et al. Unilateral retinoblastoma managed with intravenous chemotherapy versus intra-arterial chemotherapy. Outcomes based on the international classification of retinoblastoma[J]. Asia Pac J Ophthalmol (Phila), 2016, 5(2): 97-103. DOI: 10.1097/APO.0000000000000172.
|
15. |
Munier FL, Mosimann P, Puccinelli F, et al. First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment[J]. Br J Ophthalmol, 2017, 101(8): 1086-1093. DOI: 10.1136/bjophthalmol-2016-309298.
|